BARNES-JEWISH HOSPITAL
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
About Us
News & Events
Maps & Locations
Contact Us
Google Search
PATIENT AND VISITOR INFORMATION
TREATMENT PROGRAMS
PREVENTION AND SCREENING
RESEARCH
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Home
Treatment Programs
Types of Cancer
Clinical Trial Search Results
Share
Leukemia
NCI Information
Clinical Trials
Leukemia Trials
Bone Marrow Transplant (BMT) Trials
Support Groups
Effects of Treatment
Patient Stories
Leukemia Podcasts and Videos
Bone Marrow and Stem Cell Transplantation
Treatment Team
NEW SEARCH
RETURN TO SEARCH RESULTS
Number:
201108083
Principal Investigator:
Schroeder, Mark
Title:
A Phase II Trial Evaluating the Safety and Efficacy of Plerixafor and Sargramostim (GM-CSF) for the Mobilization of Peripheral Blood Stem Cells (PBSCs) from Normal HLA-Matched Allogeneic Sibling Donors
Phase:
II
Disease Site:
Multiple Sites
Participating Site(s):
Main Campus
Map and Directions
South County
Map and Directions
Contact:
800-600-3606 or
info@ccadmin.wustl.edu
Description:
The main purpose of this study is to gather information about the combination of the drugs plerixafor with sargramostim in donors of blood-forming cells (stem cells). This study will look at how safe this combination is and how patients tolerate the treatment.
More Information:
(Links will take you off this web site)
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)